JSR Life Sciences, LLC(JLS LLC) announced today that Similis Bio, recently launched business unit focused on biosimilar development, has signed its first development and license agreement with Blau Farmaceutica(public company in Brazil B3 – BLAU3).

For more information, please visit the JLS LLC’s release page below.

https://news.jsrlifesciences.com/219569-similis-bio-partners-with-blau-farmaceutica-to-co-develop-four-biosimilar-programs